Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07463300

A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,500 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

PET/CT imaging and clinical information (age, gender, smoking history, family history of cancer, history of present illness, and several tumor biomarkers, etc.) were used to establish a hierarchical multi-modal AI framework for pathological and genetic subtyping of lung cancer

Detailed description

The multi-modal AI framework is developed to facilitate a hierarchical and precise stratification process. The first level involves the accurate differentiation between small cell lung cancer and non-small cell lung cancer (NSCLC) in patients diagnosed with lung cancer. The second level entails the further categorization of NSCLC patients into adenocarcinoma, squamous cell carcinoma, and other less prevalent subtypes. The third level involves predicting the mutation status of the EGFR driver gene, which is most-commonly observed in patients with lung adenocarcinoma. The whole cohort was divided into the training cohort (retrospective), validation cohort (retrospective), test cohort (retrospective), and prospective cohort.

Conditions

Interventions

TypeNameDescription
OTHERPET imaging analysis, data mining, and AI model developingPET imaging analysis, data mining, and AI model developing

Timeline

Start date
2024-08-01
Primary completion
2027-08-01
Completion
2027-08-01
First posted
2026-03-11
Last updated
2026-03-11

Locations

9 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07463300. Inclusion in this directory is not an endorsement.